The only thing I thought that was missing is a summary slide a. Bit like a Ghant chart of the Stenosis product, showing the achievements to date and the FDA application and reasonable expectation on approval. Also expectation regarding US insurance reimbursement codes.
It should also show a time line of the ‘Heart Failure’ product and all future major steps and approximate timelines.
Mention was made by someone on whether they have the capital needed to to sell the product.
The company needs to ‘crawl before it walks’.
Shareholders need to see some delivery before stumping up additional cash to grow.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
-0.005(2.27%) |
Mkt cap ! $138.7M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.0¢ | 21.5¢ | $216.6K | 975.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 136790 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 12554 | 2 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |